These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9727868)

  • 1. Solid-phase synthesis and on-resin cyclization of a disulfide bond peptide and lactam analogues corresponding to the major antigenic site of HIV gp41 protein.
    Limal D; Briand JP; Dalbon P; Jolivet M
    J Pept Res; 1998 Aug; 52(2):121-9. PubMed ID: 9727868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and immunological characterisation of heteroclitic peptide analogues corresponding to the 600-612 region of the HIV envelope gp41 glycoprotein.
    Du AP; Limal D; Semetey V; Dali H; Jolivet M; Desgranges C; Cung MT; Briand JP; Petit MC; Muller S
    J Mol Biol; 2002 Oct; 323(3):503-21. PubMed ID: 12381305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic properties of phage displayed peptides comprising disulfide-bonded loop of the immunodominant region of HIV-1 gp41.
    Cano A; Viveros M; Acero G; Govezensky T; Munguia ME; Gonzalez E; Soto L; Gevorkian G; Manoutcharian K
    Immunol Lett; 2004 Sep; 95(2):207-12. PubMed ID: 15388262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing of novel antigenic peptide cocktail for the detection of antibodies to HIV-1/2 by ELISA.
    Tiwari RP; Jain A; Khan Z; Kumar P; Bhrigu V; Bisen PS
    J Immunol Methods; 2013 Jan; 387(1-2):157-66. PubMed ID: 23098841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing modified and plain peptide linked enzyme immunosorbent assay (ELISA) for detection of human immunodeficiency virus type-1 (HIV-1) and type-2 (HIV-2) antibodies.
    Manocha M; Chitralekha KT; Thakar M; Shashikiran D; Paranjape RS; Rao DN
    Immunol Lett; 2003 Feb; 85(3):275-8. PubMed ID: 12663143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hydrogen peroxide for disulfide bridge formation in the synthesis of peptides with the sequence of the immunodominant epitope of HIV gp41 glycoprotein].
    Sidorova MV; Kudriavtseva EV; Antopol'skiĭ ML; Pal'keeva ME; Ovchinnikov MV; Bespalova ZhD
    Bioorg Khim; 1996 Apr; 22(4):273-9. PubMed ID: 8768265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
    Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
    AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope contiguous chains and antibody recognition in HIV-1 synthetic peptide antigens.
    Aleanzi M; Perotti N; Montaner A; Lottersberger J; Tonarelli G; Marcipar A
    J Mol Recognit; 1996; 9(5-6):631-8. PubMed ID: 9174949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the thiol/disulfide chemistry of peptides corresponding to the 603-609 disulfide loop of the human immunodeficiency virus (HIV) envelope glycoprotein gp41.
    Rabenstein DL; Russell J; Gu J
    J Pept Res; 1998 Jun; 51(6):437-43. PubMed ID: 9650718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of monoclonal antibodies to human immunodeficiency virus type 1 gp41 by HIV-1 polypeptides expressed in Escherichia coli.
    Larcher C; Bröker M; Huemer HP; Sölder B; Schulz TF; Hofbauer JM; Wachter H; Dierich MP
    FEMS Microbiol Immunol; 1990 Sep; 2(2):103-10. PubMed ID: 1701654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenicity of linear and cyclic peptides mimicking the disulfide loops in HIV-2 envelope glycoprotein: synthesis, reoxidation and purification.
    Belhadj Jrad B; Bahraoui E
    J Pept Res; 1998 May; 51(5):370-85. PubMed ID: 9606017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
    Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
    Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV.
    Mitchell WM; Ding L; Gabriel J
    AIDS; 1998 Jan; 12(2):147-56. PubMed ID: 9468363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Direct transition of S-acetamidomethyl-protected peptide 593-603 of HIV-2 gp41 into a cyclic disulfide using iodine. Study of side reactions].
    Kudriavtseva EV; Sidorova MV; Ovchinnikov MV; Bespalova ZhD; Bushuev VN; Evstigneeva RP
    Bioorg Khim; 1996 May; 22(5):370-5. PubMed ID: 8929223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
    Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
    J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface simulation synthesis: a new strategy to spy alpha-helix structure.
    Dong XN; Chen Y; Chen YH
    Vaccine; 2007 Sep; 25(36):6569-71. PubMed ID: 17055133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41.
    Gorny MK; Zolla-Pazner S
    J Virol; 2000 Jul; 74(13):6186-92. PubMed ID: 10846104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).
    Neurath AR; Strick N; Jiang S
    Virology; 1992 May; 188(1):1-13. PubMed ID: 1373549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.